Key Slides on Incorporating Opioid Use Disorder Screening and Treatment Into HIV and HCV Management

Download this slideset to learn more about the integral role infectious disease specialists and hepatologists can play in combatting the opioid use disorder (OUD) epidemic, including essential strategies for integrating OUD screening, evaluation, and treatment into HIV and HCV care settings.
Sandra Springer, MD
Program Director
Christian Ramers Headshot
Christian B. Ramers, MD, MPH
Format: Microsoft PowerPoint (.ppt)
File Size: 1.95 MB
Released: February 6, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
American Society of Addiction Medicine
Educational grant provided by:
Gilead Sciences

Related Content

Interim results from the Phase II CALIBRATE study of lenacapavir in treatment-naive PLWH, reported by Clinical Care Options (CCO) from IAS 2021

Released: July 24, 2021

REACH study: adherence to dapivirine vaginal ring and oral PrEP among African females 16-21 years, in Clinical Care Options (CCO) report from IAS 2021

Released: July 24, 2021

GEMS: ART resistance, adherence in persons with HIV on PrEP in Sub-Saharan Africa, reported by Clinical Care Options (CCO) from IAS 2021

Released: July 24, 2021

Dr Joseph Eron and Clinical Care Options (CCO): Weight gain in initial ART, GEMINI, ADVANCE trials, and more

Joseph J. Eron, Jr., MD Released: July 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue